Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR6 | P50406 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.31 |
| ▸ | AXL | P30530 | 1/20 | 0.31 |
| ▸ | CSNK1D | P48730 | 1/20 | 0.31 |
| ▸ | MERTK | Q12866 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6948765 | 1.00 | HTR6 (0.35) | HTR6CYP2D6AXLCSNK1DMERTK | |
| SCHEMBL6948094 | 0.92 | — | — | |
| Hydrochloric Acid SCHEMBL6946346 | 0.90 | TSHR (0.32) | — | |
| Hydrochloric Acid SCHEMBL6953382 | 0.78 | TSHR (0.33) | — | |
| SCHEMBL31209022 | 0.76 | HTR6 (0.41) | HTR6CYP2D6AXLCSNK1DMERTK | |
| Hydrochloric Acid SCHEMBL31014809 | 0.71 | HTR6 (0.46) | HTR6CYP2D6AXLMERTK | |
| SCHEMBL6945010 | 0.69 | — | — | |
| SCHEMBL31015303 | 0.69 | HTR6 (0.55) | HTR6AXLMERTK | |
| Hydrochloric Acid SCHEMBL6949704 | 0.69 | — | — | |
| SCHEMBL31209551 | 0.68 | HTR6 (0.44) | HTR6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0587800-B1 | IMMUNOMODULATORY AZASPIRANES | ANORMED INC (CA) | 2003-04-02 | — | — | EP | disclosed |
| EP-0654997-A4 | COMPOSITIONS OF SUBSTITUTED AZASPIRANES AND METHODS OF TREATING PSORIASIS THEREWITH. | SMITHKLINE BEECHAM CORP (US) | 1997-09-17 | — | — | EP | disclosed |
| EP-0771199-A1 | METHODS | SMITHKLINE BEECHAM CORPORATION (US) | 1997-05-07 | — | — | EP | disclosed |
| US-5591748-A | Immunomodulatory azaspiranes | SMITHKLINE BEECHAM CORPORATION (US) | 1997-01-07 | — | — | US | disclosed |
| EP-0727993-A4 | — | — | 1996-10-02 | — | — | EP | disclosed |
| EP-0727993-A1 | (NON DESCRIPTIVE)-A METHOD FOR DELAYING HIV INDIVIDUAL AIDS BY ADMINISTRATION OF SUBSTITUTED AZASPIRANE COMPOUNDS | SMITHKLINE BEECHAM CORPORATION (US) | 1996-08-28 | — | — | EP | disclosed |
| WO-1996003123-A1 | METHODS | SMITHKLINE BEECHAM CORPORATION (US) | 1996-02-08 | — | — | WO | disclosed |
| US-5455247-A | Methods for the treatment of hyperlipidemia using azaspiranes | SMITHKLINE BEECHAM CORPORATION (US) | 1995-10-03 | — | — | US | disclosed |
| EP-0654997-A1 | COMPOSITIONS OF SUBSTITUTED AZASPIRANES AND METHODS OF TREATING PSORIASIS THEREWITH | SMITHKLINE BEECHAM CORPORATION (US) | 1995-05-31 | — | — | EP | disclosed |
| WO-1995003046-A1 | A METHOD OF INHIBITING THE PRODUCTION OF HIV | SMITHKLINE BEECHAM CORPORATION (US) | 1995-02-02 | — | — | WO | disclosed |
| WO-1995003048-A1 | ANTI-HIV AZASPIRANES | SMITHKLINE BEECHAM CORPORATION (US) | 1995-02-02 | — | — | WO | disclosed |
| WO-1995003047-A1 | HUMAN IMMUNODEFICIENCY VIRUS TREATMENTS | SMITHKLINE BEECHAM CORPORATION (US) | 1995-02-02 | — | — | WO | disclosed |
| EP-0609335-A4 | METHODS FOR THE TREATMENT OF HYPERLIPIDEMIA USING AZASPIRANES. | SMITHKLINE BEECHAM CORP (US) | 1994-10-12 | — | — | EP | disclosed |
| EP-0609335-A1 | METHODS FOR THE TREATMENT OF HYPERLIPIDEMIA USING AZASPIRANES | SMITHKLINE BEECHAM CORPORATION (US) | 1994-08-10 | — | — | EP | disclosed |
| WO-1994004151-A1 | COMPOSITIONS OF SUBSTITUTED AZASPIRANES AND METHODS OF TREATING PSORIASIS THEREWITH | SMITHKLINE BEECHAM CORPORATION (US) | 1994-03-03 | — | — | WO | disclosed |
| WO-1993015735-A1 | (NON DESCRIPTIVE)-A METHOD FOR DELAYING HIV INDIVIDUAL AIDS BY ADMINISTRATION OF SUBSTITUTED AZASPIRANE COMPOUNDS | SMITHKLINE BEECHAM CORPORATION (US) | 1993-08-19 | — | — | WO | disclosed |
| WO-1993007871-A1 | METHODS FOR THE TREATMENT OF HYPERLIPIDEMIA USING AZASPIRANES | SMITHKLINE BEECHAM CORPORATION (US) | 1993-04-29 | — | — | WO | disclosed |
| WO-1992022294-A1 | IMMUNOMODULATORY AZASPIRANES | SMITHKLINE BEECHAM CORPORATION (US) | 1992-12-23 | — | — | WO | disclosed |